CBLL Stock Summary and Trading Ideas (Ceribell | NASDAQ:CBLL)

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Ceribell trades on the NASDAQ stock market under the symbol CBLL.

As of November 5, 2026, CBLL stock price declined to $26.39 with 333,800 million shares trading.

CBLL has a beta of 0.60, meaning it tends to be less sensitive to market movements. CBLL has a correlation of 0.02 to the broad based SPY ETF.

CBLL has a market cap of $1.01 billion. This is considered a Small Cap stock.

Last quarter Ceribell reported $29 million in Revenue and -$.55 earnings per share. This beat revenue expectation by $182,240 and missed earnings estimates by -$.04.

The top ETF exchange traded funds that CBLL belongs to (by Net Assets): VTI, IWM, IWO, VXF, VTWO.

CBLL has outperformed the market in the last year with a price return of +141.7% while the SPY ETF gained +10.9%. CBLL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +42.5% and -2.8%, respectively, while the SPY returned -3.6% and -4.1%, respectively.

CBLL support price is $26.33 and resistance is $28.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBLL shares will trade within this expected range on the day.